CELGENE

CELGENE

Displaying 10 out of 26 results

  1. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headqu

    Bristol-Myers profit slightly tops Wall Street view on blood thinner sales

    U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for US$74 billion, posted slightly ...
  2. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured at the headqu

    Bristol-Myers says shareholders vote to approve Celgene takeover

    Bristol-Myers Squibb Inc's shareholders voted to approve the drugmaker's US$74 billion takeover of biotech Celgene Corp on Friday despite a ...
  3. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal

    Proxy advisory firm Institutional Shareholder Services on Friday recommended shareholders of drugmaker Bristol-Myers Squibb Co shareholders vote ...
  4. New Content Item

    US patent court rejects Alvogen's challenge for Celgene's Revlimid

  5. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers tells opponents Celgene deal is 'best path'

    U.S. drugmaker Bristol-Myers Squibb urged shareholders on Wednesday to support its planned takeover of Celgene Corp, as it faces opposition to the ...
  6. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Starboard to vote against Celgene/Bristol deal, move ahead with proxy

    Bristol-Myers Squibb Co expressed disappointment on Thursday with the opposition of its top shareholder to a US$74 billion takeover of Celgene ...
  7. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Top Bristol-Myers shareholder comes out against US$74 billion Celgene deal

    Bristol-Myers Squibb Co's top shareholder Wellington Management said on Wednesday that it did not support the U.S. drugmaker's US$74 billion ...
  8. New Content Item

    Celgene profit beats as psoriasis drug sales surge

  9. Bristol-Myers Squibb

    Drug maker Bristol-Myers Squibb to buy Celgene in US$74b deal

  10. NYSE Feb28

    US stocks fall again on rate worries, Dow loses 1.5%